Effect of simvastatin and atorvastatin on serum vitamin D and bone mineral density in hypercholesterolemic patients: A cross-sectional study

Journal of Osteoporosis

Volumn 2014, Issue , 2014, Pages

  Thabit, Abrar ^a   Alhifany, Abdullah ^b   Alsheikh, Razan ^a   Namnqani, Sameh ^c   Al Mohammadi, Ameen ^a   Elmorsy, Soha ^c   Qari, Mohammed ^a   Ardawi, Mohammed ^a  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^b UMM AL QURA UNIVERSITY   (Saudi Arabia)

^c King Abdullah Medical City ^*  (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ATORVASTATIN; SIMVASTATIN;

ADULT; ARTICLE; BONE DENSITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG EFFICACY; FEMALE; FEMUR NECK; HUMAN; HYPERCHOLESTEROLEMIA; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TREATMENT OUTCOME; VITAMIN BLOOD LEVEL;

EID: 84907403240     PISSN: 20908059     EISSN: 20420064     Source Type: Journal    
DOI: 10.1155/2014/468397     Document Type: Article

References (22)

1. L. Brunton, J. Lazo, and K. Parker, Goodman & Gilman's the Pharmacological Basis of Therapeutics, McGraw-Hill, New York, NY, USA, 13th edition, 2008.
2. P. Thavendiranathan, A. Bagai, M. A. Brookhart, and N. K. Choudhry, "Primary prevention of cardiovascular diseases with statin therapy: ameta-analysis of randomized controlled trials," Archives of Internal Medicine, vol. 166, no. 21, pp. 2307-2313, 2006.
3. P. van der Harst, A. A. Voors, W. H. van Gilst,M. Böhm, and D. J. van Veldhuisen, "Statins in the treatment of chronic heart failure: a systematic review," PLoS Medicine, vol. 3, no. 8, article e333, 2006.
4. M. Falagas, G. C. Makris, D. K.Matthaiou, and P. I. Rafailidis, "Statins for infection and sepsis: a systematic review of the clinical evidence," Journal of Antimicrobial Chemotherapy, vol. 61, no. 4, pp. 774-785, 2008.
5. D. L. Sparks, R. J. Kryscio, M. N. Sabbagh, D. J. Connor, L. M. Sparks, and C. Liebsack, "Reduced risk of incident AD with elective statin use in a clinical trial cohort," Current Alzheimer Research, vol. 5, no. 4, pp. 416-421, 2008.
6. L. B. Goldstein, P. Amarenco, M. Lamonte et al., "Relative effects of statin therapy on stroke and cardiovascular events in men and women: secondary analysis of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) study [abstract]," Stroke, vol. 39, no. 9, pp. 2444-2448, 2008.
7. A. M. Abeles and M. H. Pillinger, "Statins as antiinflammatory and immunomodulatory agents: a future in rheumatologic therapy?" Arthritis & Rheumatism, vol. 54, no. 2, pp. 393-407, 2006.
8. P. Anderson, J. Knoben, and G. Troutman, Handbook of Clinical Drug Data, McGrow-Hill, New York, NY, USA, 10th edition, 2002.
9. M. Sadat-Ali and A. Alelq, "Osteoporosis among male Saudi Arabs: a pilot study," Annals of Saudi Medicine, vol. 26, no. 6, pp. 450-454, 2006.
10. World Health Organization, "Assessment of fracture risk and its application to screening for postmenopausal osteoporosis," Tech. Rep. 843,WHO, Geneva, Switzerland, 1994.
11. J. S. Adams, T. L. Clemens, J. A. Parrish, and M. F. Holick, "Vitamin-D synthesis and metabolism after ultraviolet irradiation of normal and vitamin-D-deficient subjects," The New England Journal of Medicine, vol. 306, no. 12, pp. 722-725, 1982.
12. B. W. Hollis and W. B. Pittard III, "Evaluation of the total fetomaternal vitamin D relationships at term: evidence for racial differences," The Journal of Clinical Endocrinology & Metabolism, vol. 59, no. 4, pp. 652-657, 1984.
13. A. M. Parfitt, J. C. Gallagher, R. P. Heaney, C. C. Johnston, R. Neer, and G. D. Whedon, "Vitamin D and bone health in the elderly," American Journal of Clinical Nutrition, vol. 36, no. 5, pp. 1014-1031, 1982.
14. M. F. Holick, "Vitamin D deficiency," The New England Journal of Medicine, vol. 357, no. 3, pp. 266-281, 2007.
15. A. C. Cruz and B. L. Gruber, "Statins and osteoporosis: can these lipid-lowering drugs also bolster bones?" Cleveland Clinic Journal of Medicine, vol. 69, no. 4, pp. 277-288, 2002.
16. C. Hatzigeorgiou and J. L. Jackson, "Hydroxymethylglutarylcoenzyme A reductase inhibitors and osteoporosis: a metaanalysis," Osteoporosis International, vol. 16, no. 8, pp. 990-998, 2005.
17. J. L. Pérez-Castrillón, G. Vega, L. Abad et al., "Effects of atorvastatin on vitamin D levels in patients with acute ischemic heart disease," American Journal of Cardiology, vol. 99, no. 7, pp. 903-905, 2007.
18. L. Rejnmark, N. H. Buus, P. Vestergaard et al., "Effects of simvastatin on bone turnover and BMD: a 1-year randomized controlled trial in postmenopausal osteopenic women," Journal of Bone and Mineral Research, vol. 19, no. 5, pp. 737-744, 2004.
19. M. M. Ardawi, A. A.Maimani, T. A. Bahksh, A. A. Rouzi, M. H. Qari, and R. M. Raddadi, "Reference intervals of biochemical bone turnover markers for Saudi Arabian women: a crosssectional study," Bone, vol. 47, no. 4, pp. 804-814, 2010.
20. B. Uzzan, R. Cohen, P. Nicolas, M. Cucherat, and G. Perret, "Effects of statins on bone mineral density: a meta-analysis of clinical studies," Bone, vol. 40, no. 6, pp. 1581-1587, 2007.
21. S. Chuengsamarn, S. Rattanamongkoulgul, S. Suwanwalaikorn, S. Wattanasirichaigoon, and L. Kaufman, "Effects of statins vs. non-statin lipid-lowering therapy on bone formation and bone mineral density biomarkers in patients with hyperlipidemia," Bone, vol. 46, no. 4, pp. 1011-1015, 2010.
22. D. S. Grimes, "Are statins analogues of vitamin D?" The Lancet, vol. 368, no. 9529, pp. 83-86, 2006.